/
/
/

GKB Ophthalmics Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Share Price Live Stats

Open (₹)64.25
Volume (₹)1,305.00
High (₹)71.99
Upper Circuit76.40
Low (₹)64.25
Lower Circuit62.52
Prev Close69.46
52W High (₹)76.90
Price66.09
52W Low (₹)45.25

Share Market Cap & Key Ratios Overview

M.Cap (₹)35.01 Cr
Div. Yield (%)0.00
PE Ratio10.80
Debt to Equity0.22
Price to Book0.50
Book Value104.82
EPS (TTM)6.43
Face Value10.00
ROE (%)5.77

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
POLYMED-ANSE
NURECA-TNSE
GKB-BNSE
LTP
1W Low
1W High
Market cap (₹)
1716-11.75 (-0.68%)
1693.45
1771.75
17,504Cr
346+3.6 (1.05%)
330.05
358
324Cr
66.09+3.59 (5.74%)
62.51
75.52
35Cr

Key Highlights of GKB Ophthalmics Ltd’s P&L

In 2026-03-31, GKB Ophthalmics Ltd reported total revenue of ₹151.31Cr, compared with ₹110.32Cr in 2025-03-31, reflecting GKB Ophthalmics Ltd turnover.

Depreciation was ₹3.24Cr and finance costs were ₹2.67Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹3.1Cr in 2026-03-31 as compared to ₹-₹6.73Cr in 2025-03-31.

Net Profit (PAT) was ₹1.22Cr in 2026-03-31 compared with ₹-₹7.04Cr in 2025-03-31.

Earnings per share (EPS) were ₹2.42 in 2026-03-31, compared with ₹-13.98 in 2025-03-31.